AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Vaccine may be 100% effective in preventing HPV 16. (Large Phase III Study).

OB GYN News

| December 01, 2002 | Tucker, Mariam E. | COPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

CHICAGO -- A human papillomavirus vaccine has shown 100% efficacy against carcinogenic type 16 HPV at 3 years, Laura A. Koutsky Ph.D., reported at the annual meeting of the Infectious Diseases Society of America.

Merck's experimental vaccine, composed of viruslike particles, is directed against HPV types 6, 11, 16, and 18. In a 16-center phase III study looking just at HPV 16, 1,533 HPV-negative women aged 16-23 years with no prior abnormal Pap tests were given three doses of vaccine or placebo. The vaccine was well tolerated, and all but two women (99.7%) seroconverted, said Dr. Koutsky professor of epidemiology in the HPV Research Group at the University of Washington, Seattle.

At 36 months, 41 women from the placebo group had ...

Related articles from newspapers, magazines, journals, and more
StressGen initiates HspE7 Phase III trial in HPV-related anal dysplasia.
Press release article from: PR Newswire November 6, 2000 700+ words
...patient treatment in a Phase III clinical trial to...papilloma virus (HPV). HPV is one of...basis of the new Phase III trial," said Dr...patients with various HPV types, including...based therapeutic for HPV- related diseases...in StressGen's Phase III ...
New HPV vaccine shown to prevent early cervical Ca: another vaccine also is in...
Magazine article from: Internal Medicine News Boschert, Sherry November 1, 2005 700+ words
...from cervical cancer each year. HPV also can cause anal cancer in men...infection. Gardasil is one of two HPV vaccines in phase III clinical trials. The other, called Cervarix, immunizes against HPV 16 and 18 and uses a novel adjuvant...
CIN2/CIN3, early cervical Ca prevented by HPV vaccine: two human papillomavirus...
Magazine article from: Skin & Allergy News Boschert, Sherry November 1, 2005 700+ words
...each year from cervical cancer. HPV also can cause anal cancer in...infection. Gardasil is one of two HPV vaccines currently in phase III clinical trials. The other, called Cervarix, immunizes against HPV 16 and 18 and uses a novel adjuvant...
GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in...
Press release article from: Business Wire November 13, 2008 700+ words
...human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to...evaluating efficacy of any HPV vaccine in preventing...placebo-controlled, Phase III study was designed to...GARDASIL in males against HPV 6, 11, 16, and 18...
GARDASIL, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing...
Newspaper article from: Virus Weekly December 2, 2008 700+ words
...human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to...evaluating efficacy of any HPV vaccine in preventing...placebo-controlled, Phase III study was designed to...GARDASIL in males against HPV 6, 11, 16, and 18...
HPV vaccine may prevent 70% of invasive cervical ca cases; phase III...
Magazine article from: OB GYN News September 1, 2003 700+ words
...vaccine now in international phase III trials is expected to...human papillomavirus (HPV) can infect the human...incidence of persistent HPV-16 infection in those...have been 41 cases of HPV infection in the phase...prevention of infection. The phase III trial is intended to ...
Stressgen completes early enrollment in its Phase III Trial for HspE7 for Anal...
Press release article from: PR Newswire August 1, 2001 700+ words
...patient enrollment in its Phase III clinical trial investigating...human papillomavirus (HPV) has reached its target...completion of enrollment in this Phase III AIN trial, coupled with...to targeting HspE7 for HPV-related diseases, the...
Stressgen announces statistically significant results with HspE7 to treat RRP;...
Press release article from: PR Newswire June 10, 2003 700+ words
...achieved and leads to a Phase III confirming trial. The...providing further support for a Phase III RRP program. HspE7 was...commercialization of HspE7 for HPV-related diseases. In...with RRP, Stressgen has a Phase III clinical trial for the...
For more facts and information, see all results

Source: HighBeam Research, Vaccine may be 100% effective in preventing HPV 16. (Large Phase III...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA